The role of HRASLS3/AdPLA in adipocyte triglyceride metabolism suggests that inhibition may be a useful strategy to prevent and treat obesity [13, 16], and future studies will therefore likely focus on the design of inhibitors [16] and on strategies to regulate this enzyme. The gene discussed is PLAAT3; the disease is obesity disorder.